Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Institut fĂĽr Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Takeda
Mayo Clinic
Shanghai Junshi Bioscience Co., Ltd.
University of Washington
American Regent, Inc.
Techsomed Medical Technologies LTD
Eureka Therapeutics Inc.
National Institutes of Health Clinical Center (CC)
UniversitĂ Vita-Salute San Raffaele
Ethicon, Inc.
Johns Hopkins University
LEO Pharma
LEO Pharma
Georgetown University
Omega Therapeutics
M.D. Anderson Cancer Center
Centre Hospitalier de la cĂ´te Basque
National Institutes of Health Clinical Center (CC)
Pfizer
Pfizer
University Hospital Tuebingen
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
IHU Strasbourg
Ethicon, Inc.
Fusion Pharmaceuticals Inc.
Columbia University
Canadian Cancer Trials Group
American College of Radiology
City of Hope Medical Center
H. Lee Moffitt Cancer Center and Research Institute
Bristol-Myers Squibb
H. Lee Moffitt Cancer Center and Research Institute
Imunon
Eureka Therapeutics Inc.
National Institutes of Health Clinical Center (CC)
Washington University School of Medicine
Big Ten Cancer Research Consortium
BTG International Inc.
Cellxpert Biotechnology Corp.
Insel Gruppe AG, University Hospital Bern
Wake Forest University Health Sciences
University Health Network, Toronto
Milton S. Hershey Medical Center
SC Liver Research Consortium, LLC
University of California, San Diego
New Mexico Cancer Research Alliance
University of Texas Southwestern Medical Center